Bioactive components to inhibit foam cell formation in atherosclerosis.

Singh, Sanjiv; Changkija, Senti; Mudgal, Rajat; Ravichandiran, V

Singh, Sanjiv; Changkija, Senti; Mudgal, Rajat; Ravichandiran, V.

Afiliação

Singh S; Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Export Promotions Industrial Park (EPIP), Industrial Area, Vaishali District, Hajipur, Bihar, 844102, India. sanjivpg2006@yahoo.com.
Changkija S; Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Export Promotions Industrial Park (EPIP), Industrial Area, Vaishali District, Hajipur, Bihar, 844102, India.
Mudgal R; Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Export Promotions Industrial Park (EPIP), Industrial Area, Vaishali District, Hajipur, Bihar, 844102, India.
Ravichandiran V; Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Export Promotions Industrial Park (EPIP), Industrial Area, Vaishali District, Hajipur, Bihar, 844102, India.

Mol Biol Rep ; 49(3): 2487-2501, 2022 Mar.

Article em En | MEDLINE | ID: mdl-35013861

Assuntos

Aterosclerose; Células Espumosas; Aterosclerose/metabolismo; Colesterol/metabolismo; Expressão Gênica; Humanos; Lipoproteínas LDL/metabolismo; Macrófagos/metabolismo

Palavras-chave

Atherosclerosis; Bioactive components; Endothelial dysfunction; Foam cell formation; Herbal medicine; Macrophages

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Aterosclerose / Células Espumosas Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google